CGON · CG Oncology, Inc. · Executive Compensation
$68.71
+1.33 (+1.97%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$6.24B
Shares
88.64M
Volume · Oct 5
788.35K
Avg daily vol (3M)
896.56K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Arthur Kuan | Chief Executive Officer | $11,928,401 |
| Ambaw Bellete | President and Chief Operating Officer | $4,815,391 |
| Vijay Kasturi | Chief Medical Officer | $3,599,947 |
| Joshua F. Patterson | General Counsel, Chief Compliance Officer, and Secretary | $2,364,380 |
| Corleen M. Roche | Prior Chief Financial Officer Robert Lapetina (Prior Interim Principal Financial and Accounting Officer) | $2,322,299 |
| Jim DeTore | Chief Financial Officer | $96,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Arthur Kuan | Chief Executive Officer | $11,172,793 |
| Corleen M. Roche | Chief Financial Officer | $9,845,800 |
| Ambaw Bellete | President and Chief Operating Officer | $5,241,391 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Arthur Kuan | Chief Executive Officer | $3,933,996 |
| Ambaw Bellete | President and Chief Operating Officer | $3,029,535 |
| Corleen M. Roche | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Arthur Kuan | President | Appointed | 2026-05-26 |
| Jim DeTore | Chief Financial Officer | Appointed | 2026-04-13 |
| Simone Song | Board | Resigned | 2025-11-26 |
| Christina Rossi | Class II director | Appointed | 2025-11-26 |
| Jim DeTore | interim principal financial and accounting officer | Appointed | 2025-11-14 |
| Robert Lapetina | interim principal financial and accounting officer | Resigned | 2025-11-14 |
| Robert Lapetina | principal financial and accounting officer | Appointed | 2025-07-11 |
| Corleen Roche | Chief Financial Officer | Resigned | 2025-07-11 |